Evidence map›Paper›PMID 34991948›Full record

ArticleSchizophrenia research2022

Paradigm shift on the concept of schizophrenia that matches with both academic and clinical needs.

Akira Sawa, Kun Yang, Nicola G Cascella

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Schizophrenia research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Akira SawaDepartment of Psychiatry, Johns Hopkins University School of Medicine, United States; Department of Neuroscience, Johns Hopkins University School of Medicine, United States; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, United States; Department of Genetic Medicine, Johns Hopkins University School of Medicine, United States; Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, United States. Electronic address: asawa1@jhmi.edu.
Kun YangDepartment of Psychiatry, Johns Hopkins University School of Medicine, United States.
Nicola G CascellaDepartment of Psychiatry, Johns Hopkins University School of Medicine, United States.

Funding

Project 3P50MH094268 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SAWA, AKIRA · 2011 to 2020
$19.9M
High throughput marker for cognitive deficit: cellular autofluorescenceR01MH107730 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SAWA, AKIRA · 2018 to 2022
$3.0M
DISC1-dependent defects in neural fate, corticogenesis and cognition in psychosisR01MH105660 · NIMH · JOHNS HOPKINS UNIVERSITY · PI ISHIZUKA, KOKO, SAWA, AKIRA · 2014 to 2018
$2.8M
Oxidative stress and schizophrenia: combination of cell biology and brain imagingR01MH092443 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SAWA, AKIRA · 2011 to 2015
$1.8M
Leveraging ethical dissension among capacity, beneficence and justice in clinical trials of neurotherapeutics in the severely disabled: lessons from schizophreniaRF1MH121362 · NIMH · UNIVERSITY OF COLORADO DENVER · PI DAVIS, RACHEL A, GAULT, JUDITH MORSE · 2019 to 2019
$1.6M
NIMH NIH HHS P50 MH094268NIMH NIH HHS R01 MH092443NIMH NIH HHS R01 MH105660NIMH NIH HHS R01 MH107730NIMH NIH HHS RF1 MH121362
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

SchizophreniaHumansSchizophrenic Psychology

Identifiers

PMID34991948
PMCPMC10503824

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.